ClinicalTrials.gg
CompletedNCT04853654Updated Jan 13, 2022

Investigation of the Effects of Selective Exercise Training in Multiple Sclerosis

An interventional study of exercise in Multiple Sclerosis and Exercise, sponsored by Sanko University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by Sanko University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Sep 2018, registered Apr 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Selective exercise programs specific to muscle groups, with the workload to be done in line with the muscle's own structure, can enable more strength to be released with less fatigue in MS, and this increase in strength can increase balance and functional activities. to determine the effects of type training (selective exercise training), eccentric and concentric training on function, balance, fatigue and muscle architecture.

Read the detailed description

Recovery and enhancement of muscle function in MS is one of the main goals in physiotherapy and rehabilitation. In literature studies, it is stated that eccentric and concentric exercises are effective exercise approaches in increasing strength and reducing fatigue. However, the best exercise method is not yet clear in terms of providing better performance adaptation with less fatigue. Considering the architectural features of the lower extremity muscles, it is aimed to increase the angle of pennation with programs that include concentric strengthening of the quadriceps, gastro-soleus and gastrocnemius muscles, which are suitable muscle groups to produce large forces by design. With programs that include eccentric strengthening of the hamstring and tibialis anterior muscles that function in a wide range of motion and have high excursion ability, it is aimed to increase fiber length.

02

Conditions studied

  • Multiple Sclerosis
  • Exercise

Keywords

  • multiple sclerosis
  • muscle architecture
  • Eccentric Exercise
  • Concentric Exercise
03

In context

Multiple Sclerosis

3,525 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.

This study's enrollment of 33 is below the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Sanko University is the lead sponsor of 52 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18-50,
  • With an Extended Disability Status Scale (EDSS) score of 4 or less,
  • No regular exercise habit
  • Able to walk on the treadmill,
  • No pregnancy,
  • Not receiving corticosteroid treatment in the last month,
  • Fampridine etc. in the last 1 month. not taking medication,
  • Patients who have not received Botox treatment in the last 6 months

Exclusion criteria

Exclusion Criteria:

patients who do not agree to volunteer

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Selective training

    selective training on lower extremity for 3 days/week

    Other: exercise

  • Experimental
    Downhill walking

    downhill walking training on the treadmill for 2 days/week

    Other: exercise

  • Experimental
    Uphill walking

    uphill walking training on the treadmill for 2 days/week

    Other: exercise

Interventions

  • Otherexercise

    exercise training for 8 weeks

06

What researchers measure

Primary outcomes

  1. muscle architecture parameter 1

    The pennation angle were evaluated with Ultrasound

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  2. muscle architecture parameter 2

    The fiber length were evaluated with Ultrasound

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  3. muscle architecture parameter 3

    The muscle thickness were evaluated with Ultrasound

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  4. Muscle strength

    low extremity muscles were evaluated with hand dynamometer

    Time frame: Change from Baseline at 8th weeks and 12th weeks

Secondary outcomes

  1. walking fatigue

    Walking Fatigue Index

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  2. perceived fatigue

    Fatigue Severity Scale

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  3. physical fatigue

    Modified Borg Scale before and after 6-minute walking test

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  4. static balance

    Single standing tests

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  5. dynamic balance

    4 square step tests

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  6. Functional activities 1

    timed-up go test

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  7. Functional activities 2

    2-minute walk test

    Time frame: Change from Baseline at 8th weeks and 12th weeks

  8. Functional activities 3

    25-feet walk test

    Time frame: Change from Baseline at 8th weeks and 12th weeks

07

Study locations

1 site
  • Zekiye İpek Katırcı Kırmacı
    Gaziantep, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04853654
Lead sponsor
Sanko University
Responsible party
zekiye ipek katırcı kırmacı (assistant professor, Sanko University) — Principal investigator
First posted
Apr 21, 2021
Start date
Sep 15, 2018
Primary completion
Apr 15, 2020
Completion
Jun 15, 2020
Last update
Jan 13, 2022

Study contacts

TÜZÜN FIRAT
study director · Hacettepe University
AYHAN ÖZKUR
study chair · Sanko University
AYŞE MÜNİFE NEYAL
study chair · Sanko University
ABDURRAHMAN NEYAL
study chair · Dr. Ersin Arslan Training and Research Hospital,
NEVİN ERGUN
study director · Sanko University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion